Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BM-531

😃Good
Catalog No. TXB-00085Cas No. 284464-46-6
Alias BM531, BM 531

BM-531 is a thromboxane A2 receptor (TXA2R) antagonist (IC₅₀ = 7.8 nM) and thromboxane synthase inhibitor exhibiting antiplatelet activity. It inhibits arachidonic acid-induced platelet aggregation and suppresses the second wave of ADP-induced aggregation.

BM-531

BM-531

😃Good
Purity: 97.46%
Catalog No. TXB-00085Alias BM531, BM 531Cas No. 284464-46-6
BM-531 is a thromboxane A2 receptor (TXA2R) antagonist (IC₅₀ = 7.8 nM) and thromboxane synthase inhibitor exhibiting antiplatelet activity. It inhibits arachidonic acid-induced platelet aggregation and suppresses the second wave of ADP-induced aggregation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$195-In Stock
5 mg$483-In Stock
10 mg$691-In Stock
25 mg$1,080-In Stock
50 mg$1,490-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.46%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
BM-531 is a thromboxane A2 receptor (TXA2R) antagonist (IC₅₀ = 7.8 nM) and thromboxane synthase inhibitor exhibiting antiplatelet activity. It inhibits arachidonic acid-induced platelet aggregation and suppresses the second wave of ADP-induced aggregation.
Targets&IC50
TXA2:7.8 nM
In vitro
BM-531 (0.0001-10 μM) exhibits high affinity for the thromboxane A₂ (TXA₂) receptor in homo sapiens platelets (IC₅₀ = 0.0078 μM, determined by competitive displacement of [³H]SQ-29548) [1].
BM-531 demonstrates anti-aggregatory effects in homo sapiens platelet-rich plasma (PRP), inhibiting arachidonic acid-induced platelet aggregation (ED₁₀₀ = 0.125 μM) and U-46619-induced platelet aggregation (ED₅₀ = 0.482 μM) [1].
BM-531 (10 μM) inhibits high K⁺-induced contraction in porcine uterine smooth muscle after 1 hour of treatment [2].
SynonymsBM531, BM 531
Chemical Properties
Molecular Weight398.48
FormulaC17H26N4O5S
Cas No.284464-46-6
SmilesO=C(NS(=O)(C1=CC([N+]([O-])=O)=CC=C1NC2CCCCC2)=O)NC(C)(C)C
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy BM-531 | purchase BM-531 | BM-531 cost | order BM-531 | BM-531 chemical structure | BM-531 in vitro | BM-531 formula | BM-531 molecular weight